157 related articles for article (PubMed ID: 38602692)
1. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
de Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J
JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):463-471. PubMed ID: 38602692
[TBL] [Abstract][Full Text] [Related]
2. Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma.
de Almeida JR; Noel CW; Veigas M; Martino R; Chepeha DB; Bratman SV; Goldstein DP; Hansen AR; Yu E; Metser U; Weinreb I; Perez-Ordonez B; Xu W; Kim J
BMJ Open; 2019 Dec; 9(12):e035431. PubMed ID: 31892671
[TBL] [Abstract][Full Text] [Related]
3. Pharyngeal-sparing radiation for head and neck carcinoma of unknown primary following TORS assisted work-up.
Grewal AS; Rajasekaran K; Cannady SB; Chalian AA; Ghiam AF; Lin A; LiVolsi V; Lukens JN; Mitra N; Montone KT; Newman JG; O'Malley BW; Rassekh CH; Weinstein GS; Swisher-McClure S
Laryngoscope; 2020 Mar; 130(3):691-697. PubMed ID: 31411747
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.
Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1208-1215. PubMed ID: 27812692
[TBL] [Abstract][Full Text] [Related]
5. Post-operative therapy following transoral robotic surgery for unknown primary cancers of the head and neck.
Patel SA; Parvathaneni A; Parvathaneni U; Houlton JJ; Karni RJ; Liao JJ; Futran ND; Méndez E
Oral Oncol; 2017 Sep; 72():150-156. PubMed ID: 28797451
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.
Palma DA; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Eskander A; Higgins K; Karam I; Poon I; Husain Z; Enepekides D; Hier M; Sultanem K; Richardson K; Mlynarek A; Johnson-Obaseki S; Odell M; Bayley A; Dowthwaite S; Jackson JE; Dzienis M; O'Neil J; Chandarana S; Banerjee R; Hart R; Chung J; Tenenholtz T; Krishnan S; Le H; Yoo J; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Chen J; Parker C; Wehrli B; Kwan K; Theurer J; Sathya J; Hammond JA; Read N; Venkatesan V; MacNeil SD; Fung K; Nichols AC
JAMA Oncol; 2022 Jun; 8(6):1-7. PubMed ID: 35482348
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
8. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
9. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer.
Barbon CEA; Yao CMK; Peterson CB; Moreno AC; Goepfert RP; Johnson FM; Chronowski GM; Fuller CD; Gross ND; Hutcheson KA
Otolaryngol Head Neck Surg; 2022 Sep; 167(3):484-493. PubMed ID: 34784256
[TBL] [Abstract][Full Text] [Related]
10. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
[TBL] [Abstract][Full Text] [Related]
11. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124
[TBL] [Abstract][Full Text] [Related]
12. Transoral robotic surgery for management of cervical unknown primary squamous cell carcinoma: Updates on efficacy, surgical technique and margin status.
Geltzeiler M; Doerfler S; Turner M; Albergotti WG; Kubik M; Kim S; Ferris R; Duvvuri U
Oral Oncol; 2017 Mar; 66():9-13. PubMed ID: 28249654
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
[TBL] [Abstract][Full Text] [Related]
14. Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal Primaries.
Hatten KM; O'Malley BW; Bur AM; Patel MR; Rassekh CH; Newman JG; Cannady SB; Chalian AA; Hodnett BL; Lin A; Lukens JN; Cohen RB; Bauml JM; Montone KT; Livolsi VA; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):267-273. PubMed ID: 27930761
[TBL] [Abstract][Full Text] [Related]
15. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
[TBL] [Abstract][Full Text] [Related]
16. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
[TBL] [Abstract][Full Text] [Related]
17. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer.
Hutcheson KA; Warneke CL; Yao CMKL; Zaveri J; Elgohari BE; Goepfert R; Hessel AC; Kupferman ME; Lai SY; Fuller CD; Gunn GB; Garden AS; Johnson F; Ferrarotto R; Lewin JS; Gross ND;
JAMA Otolaryngol Head Neck Surg; 2019 Nov; 145(11):1053-1063. PubMed ID: 31556933
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract][Full Text] [Related]
19. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
20. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study.
Fradet L; Charters E; Gao K; Froggatt C; Palme C; Riffat F; Nguyen K; Wu R; Milross C; Clark JR
ANZ J Surg; 2022 Mar; 92(3):511-517. PubMed ID: 35018703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
